Article

Expression of p53 and C-Myc in pancreatic ductal adenocarcinoma and their association with clinicopathological, molecular, prognostic and survival variables in patients of Fundación Santa Fe de Bogotá University Hospital, between 2009-2022.

2025-05-07

Abstract excerpt

<h4>Background: </h4> Pancreatic ductal adenocarcinoma (PDAC) has a high mortality rate despite treatment. This study compares the expression of C-Myc and p53 with clinicopathological, molecular, and prognostic factors in PDAC patients at the Fundación Santa Fe University Hospital in Bogotá. Methodology. This descriptive-analytical study included 95 PDAC patients, 55 of whom underwent surgical resection and 40 wer...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: d436e99a-0548-5af3-b0e7-89d515a28b1c
DOI: 10.22541/au.174664998.87015473/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Expression of p53 and C-Myc in pancreatic ductal adenocarcinoma and their association with clinicopathological, molecular, prognostic and survival variables in patients of Fundación Santa Fe de Bogotá University Hospital, between 2009-2022.DOI 10.22541/au.174664998.87015473/v1Read

Molecular Profiling and Survival Outcomes in Pancreatic Ductal Adenocarcinoma: A Multicenter Real-World Study from Turkey.Semantic proximity Read

Molecular classification as prognostic factor and guide for treatment decision of pancreatic cancer.Semantic proximity Read

Comprehensive Analysis of Somatic Mutations in Driver Genes of Resected Pancreatic Ductal Adenocarcinoma Reveals KRAS G12D and Mutant TP53 Combination as an Independent Predictor of Clinical Outcome.Semantic proximity Read

<i>GATA6</i>amplification is associated with improved survival of<i>TP53</i>-mutated pancreatic cancerSemantic proximity Read

Genomic determinants of biological aggressiveness and poor prognosis of pancreatic cancers: KRAS and beyond.Semantic proximity Read

PDAC-ANN: an artificial neural network to predict Pancreatic Ductal Adenocarcinoma based on gene expressionSemantic proximity Read

Prognostic Properties of KRAS Gene Mutation Subtypes in Resected Pancreatic Ductal Adenocarcinoma.Semantic proximity Read

Validation and comparison of the molecular classifications of pancreatic carcinomasSemantic proximity Read

PDAC-ANN: an artificial neural network to predict pancreatic ductal adenocarcinoma based on gene expressionSemantic proximity Read

Early-Onset Pancreatic Ductal Adenocarcinoma: Clinical Features, Genomic Landscape, and Treatment-Mediated Survival AdvantageSemantic proximity Read

Precision Medicine in Pancreatic Ductal Adenocarcinoma: The Impact of Targeted Therapies on Survival of Patients Harboring Actionable MutationsSemantic proximity Read

Prognostic value of KRAS gene mutations in pancreatic ductal adenocarcinoma: a systematic review and meta-analysis.Semantic proximity Read